RxAdvance is now a part of nirvanaHealth. Click here to learn more.

Former Apple CEO John Sculley Accepts Position as Chairman and Chief Marketing Officer at RxAdvance, a Transformative Healthcare Company

Southborough, MA – November 15th, 2016:  Ravi Ika, founder and CEO of RxAdvance announced today that former Apple CEO, John Sculley, has accepted the expanded role as Chairman and Chief Marketing Officer at RxAdvance. John is a founding investor and has been RxAdvance Vice Chairman.

“Great entrepreneurs start with a ‘Noble Cause’. The more time I spend with Ravi, the more I appreciate that he has created something truly amazing,” says John Sculley. “After leaving Apple, I have acted as an advisor, investor, and board member in over two dozen companies. RxAdvance is the first company that has inspired me to get involved as an operating partner.”

“Through the Collaborative PBM Cloud, our disruptive solutions reduce overall pharmacy costs, specialty costs, and avoidable drug-impacted medical costs. John and I work together every day as partners. Our growth momentum is accelerating and John’s thought leadership across three vectors – consumer, high-tech, and healthcare – has helped us conceptualize and implement our differentiation,” says Ravi Ika.

 “Convincing John Sculley to join our management team was a great step forward toward positioning RxAdvance as one of the most transformative and innovative companies in healthcare. John Sculley has defined our vision at RxAdvance,” says Ravi.

Today, the United States spends nearly $3 trillion dollars on healthcare. Traditional Pharmacy Benefit Management (PBM) companies manage $370 billion of this pharmacy spend. RxAdvance defines its addressable market as much larger due to its ability to manage medical risk.

In addition to the $370 billion PBM market, RxAdvance’s unique solutions include the $120 billion specialty drug market and $350 billion avoidable drug-impacted medicalcosts, totaling to a $840 billion addressable market.

These avoidable drug-impacted medical costs are introduced into the system largely due to antiquated platforms, obsolete transactional methodologies, limited service offerings, the inability to derive actionable intelligence, and the lack of a single point of accountability in the care continuum. If optimized correctly, savings from just half of avoidable drug-impacted medical costs are more than enough to fund the uninsured and underinsured, while also reducing premiums for all Americans. This provides an opportunity for the US Healthcare System to save hundreds of billions of dollars through disruptive innovation.


Liz Thomas, 617-997-7723

RxAdvance is now nirvanaHealth.

Since 2013, the RxAdvance team has been dedicated to disrupting the healthcare industry, specifically in pharmacy benefit management. After 3 years of development, we went live with our first client in 2016 and delivered groundbreaking pharmacy benefit management services. Now that we have proven success year-after-year, we have decided to expand our impact beyond just the PBM industry—onto the payer industry. These two industries alone control the majority of the healthcare spend in the United States, including the $900+ billion of waste generated annually. With our expansion into a new portion of the industry, we have outgrown the RxAdvance name, since it does not accurately capture the scope of our healthcare reach and mission. We are excited to announce our new name and brand—nirvanaHealth. The RxAdvance name has served us well for many years and will continue to do so under nirvanaHealth.